Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments

Information

  • Research Project
  • 10260845
  • ApplicationId
    10260845
  • Core Project Number
    U19AI162130
  • Full Project Number
    1U19AI162130-01
  • Serial Number
    162130
  • FOA Number
    RFA-AI-20-008
  • Sub Project Id
  • Project Start Date
    9/1/2021 - 2 years ago
  • Project End Date
    5/31/2026 - 2 years from now
  • Program Officer Name
    BOZICK, BROOKE ALLISON
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    5/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/19/2021 - 2 years ago

Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments

Project Summary/Abstract ? Overall Component We propose multidisciplinary studies to comprehensively evaluate the roles of contact, fomite, sprayborne, and aerosol transmission and how they interact with ventilation to facilitate human-to-human influenza transmission using a suite of innovative technologies for improved sampling, fractionation, culture, and characterization of influenza virus aerosols. These studies leverage our highly diverse team of experts in bioengineering, aerosol science, human challenge and clinical trials, influenza virology and immunology, infectious diseases epidemiology, aerobiology, and computational fluid dynamics. The proposal is organized around two research projects and three cores. In Research Project 1, ?Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)? we will study the impact of two interventions a) ventilation and air sanitation and b) hand hygiene and face shields on transmission of circulating seasonal influenza from naturally infected cases to serologically susceptible volunteers. We will use the RCT to test hypotheses that aerosol transmission is the dominant mode, is associated with greater frequency of fever and systemic symptoms in secondary cases, and that in the absence of hemagglutination inhibiting antibodies, antibodies against other targets will strongly correlate with protection from infection and disease. In Research Project 2, ?Developing and Applying Analytical Models of Influenza Transmission? we will use computational fluid dynamics and novel new aerosol measurements to a) design interventions and sampling strategies for the RCT enabling us to distinguish short- and long-range aerosol transmission from sprayborne transmission, b) define the Wells-Riley aerosol quantum of infection in terms of measurable quantities and assess risk at the recipient breathing zone level in both well-mixed and non-well-mixed indoor air conditions, and c) extend our models to household and animal studies and create practical analytical tools for public health scientists to collect data and assess risk in the field. The Research Projects will be enabled by an Advanced Bioaerosol Technology Core (ABTC) that will develop new viral aerosol sampling and culture systems and methods for both ambient and exhaled breath sampling that will validate the RCT design and provide critical inputs to the analytical models. A Clinical and Biostatistics Core (CBC) will provide the clinical infrastructure to perform the complex quarantine studies. The Administrative Core will manage these tightly integrated components to mold transdisciplinary insights into the dynamics and drivers of influenza transmission between humans.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U19
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    2552332
  • Indirect Cost Amount
    471754
  • Total Cost
    3024086
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF PUBLIC HEALTH
  • Funding ICs
    NIAID:3024086\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZAI1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIV OF MARYLAND, COLLEGE PARK
  • Organization Department
    PUBLIC HEALTH & PREV MEDICINE
  • Organization DUNS
    790934285
  • Organization City
    COLLEGE PARK
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    207425141
  • Organization District
    UNITED STATES